Twist Bioscience Corporation
NASDAQ: TWST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Emily Marine Leproust
- Employees
- 923
- Headquarters
- South San Francisco, United States
- IPO year
- 2018
- Market cap
- $5.5B
- Website
- https://www.twistbioscience.com
Loading TWST…
Loading profile data…Frequently asked questions about TWST
What does Twist Bioscience Corporation (TWST) do?
Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses...
Where does TWST trade?
Twist Bioscience Corporation (TWST) trades on the NASDAQ Global Select.
What sector is TWST in?
Twist Bioscience Corporation (TWST) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Twist Bioscience Corporation?
Emily Marine Leproust is the chief executive officer of Twist Bioscience Corporation (TWST).
Where is Twist Bioscience Corporation headquartered?
Twist Bioscience Corporation is headquartered in United States.
Does TWST pay a dividend?
Twist Bioscience Corporation (TWST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TWST go public?
Twist Bioscience Corporation (TWST) completed its initial public offering in 2018.